Parallel screening for ALK, MET and ROS1 alterations in non-small cell lung cancer with implications for daily routine testing
作者： Philipp Jurmeister , Dido Lenze , Erika Berg , Stefanie Mende , Frank Schäper
DOI: 10.1016/J.LUNGCAN.2014.11.018
关键词:
摘要: Objectives ALK, MET and ROS1 are prognostic and predictive markers in NSCLC, which need to be implemented in daily routine. To evaluate different detection approaches and …
elsevier.com
sci-hub.se 参考文章(48)
Ozgur Cem Erkin, Jhingook Kim, Jin Seok Ahn, Jungsuk An, Myung Ju Ahn, Jinwon Seo, Keunchil Park, Young Mog Shim, Young Kee Shin, Yoon La Choi, Kyung Song, Sanghui Park, Chang Ok Sung, Joungho Han, High MET copy number and MET overexpression: poor outcome in non-small cell lung cancer patients. Histology and Histopathology. ,vol. 27, pp. 197- 207 ,(2012) , 10.14670/HH-27.197
Yan Feng, Eugen C. Minca, Christopher Lanigan, Angen Liu, Wei Zhang, Lihong Yin, Nathan A. Pennell, Carol Farver, Raymond Tubbs, Patrick C. Ma, High MET Receptor Expression But Not Gene Amplification in ALK 2p23 Rearrangement Positive Non–Small-Cell Lung Cancer Journal of Thoracic Oncology. ,vol. 9, pp. 646- 653 ,(2014) , 10.1097/JTO.0000000000000145
Lynette M. Sholl, Stanislawa Weremowicz, Stacy W. Gray, Kwok-Kin Wong, Lucian R. Chirieac, Neal I. Lindeman, Jason L. Hornick, Combined Use of ALK Immunohistochemistry and FISH for Optimal Detection of ALK- Rearranged Lung Adenocarcinomas Journal of Thoracic Oncology. ,vol. 8, pp. 322- 328 ,(2013) , 10.1097/JTO.0B013E31827DB604
Sai-Hong Ignatius Ou, Eunice L. Kwak, Christina Siwak-Tapp, Joni Dy, Kristin Bergethon, Jeffrey W. Clark, D. Ross Camidge, Benjamin J. Solomon, Robert G. Maki, Yung-Jue Bang, Dong-Wan Kim, James Christensen, Weiwei Tan, Keith D. Wilner, Ravi Salgia, A. John Iafrate, Activity of crizotinib (PF02341066), a dual mesenchymal-epithelial transition (MET) and anaplastic lymphoma kinase (ALK) inhibitor, in a non-small cell lung cancer patient with de novo MET amplification. Journal of Thoracic Oncology. ,vol. 6, pp. 942- 946 ,(2011) , 10.1097/JTO.0B013E31821528D3
Neal I. Lindeman, Philip T. Cagle, Mary Beth Beasley, Dhananjay Arun Chitale, Sanja Dacic, Giuseppe Giaccone, Robert Brian Jenkins, David J. Kwiatkowski, Juan-Sebastian Saldivar, Jeremy Squire, Erik Thunnissen, Marc Ladanyi, Molecular Testing Guideline for Selection of Lung Cancer Patients for EGFR and ALK Tyrosine Kinase Inhibitors: Guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology Journal of Thoracic Oncology. ,vol. 8, pp. 823- 859 ,(2013) , 10.1097/JTO.0B013E318290868F
Eunhee S. Yi, Jennifer M. Boland, Joseph J. Maleszewski, Anja C. Roden, Andre M. Oliveira, Marie-Christine Aubry, Michele R. Erickson-Johnson, Bolette L. Caron, Yan Li, Hui Tang, Shawn Stoddard, Jason Wampfler, Kimary Kulig, Ping Yang, Correlation of IHC and FISH for ALK Gene Rearrangement in Non-small Cell Lung Carcinoma: IHC Score Algorithm for FISH Journal of Thoracic Oncology. ,vol. 6, pp. 459- 465 ,(2011) , 10.1097/JTO.0B013E318209EDB9
Koji Tsuta, Yoshiki Kozu, Takahiro Mimae, Akihiko Yoshida, Takashi Kohno, Ikuo Sekine, Tomohide Tamura, Hisao Asamura, Koh Furuta, Hitoshi Tsuda, c-MET/phospho-MET protein expression and MET gene copy number in non-small cell lung carcinomas. Journal of Thoracic Oncology. ,vol. 7, pp. 331- 339 ,(2012) , 10.1097/JTO.0B013E318241655F
Anne McLeer-Florin, Denis Moro-Sibilot, Adrien Melis, Dimitri Salameire, Christine Lefebvre, Françoise Ceccaldi, Florence de Fraipont, Elisabeth Brambilla, Sylvie Lantuejoul, Dual IHC and FISH Testing for ALK Gene Rearrangement in Lung Adenocarcinomas in a Routine Practice: A French Study Journal of Thoracic Oncology. ,vol. 7, pp. 348- 354 ,(2012) , 10.1097/JTO.0B013E3182381535
Spasenija Savic, Beata Bode, Joachim Diebold, Ivo Tosoni, Audrey Barascud, Betty Baschiera, Bruno Grilli, Michelle Herzog, Ellen Obermann, Lukas Bubendorf, Detection of ALK-Positive Non-Small-Cell Lung Cancers on Cytological Specimens High Accuracy of Immunocytochemistry with the 5A4 Clone Journal of Thoracic Oncology. ,vol. 8, pp. 1004- 1011 ,(2013) , 10.1097/JTO.0B013E3182936CA9
Keith M Kerr, Pulmonary adenocarcinomas: classification and reporting. Histopathology. ,vol. 54, pp. 12- 27 ,(2009) , 10.1111/J.1365-2559.2008.03176.X